Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
0.8664
+0.0064 (0.74%)
At close: Jul 8, 2025, 4:00 PM
0.8797
+0.0133 (1.54%)
After-hours: Jul 8, 2025, 7:31 PM EDT
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $3.76 million as of July 8, 2025. Its market cap has decreased by -7.40% in one year.
Market Cap
3.76M
Enterprise Value
153.32K
1-Year Change
-7.40%
Ranking
Category
Stock Price
$0.87
Market Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $3.76M, a decrease of -98.18%. That is a compound annual growth rate of -74.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2025 | 3.73M | -61.78% |
| Dec 31, 2024 | 9.77M | 269.37% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |